An investigational treatment for Ebola virus disease will receive advanced development support from the U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness...

The investigational Ebola treatment mAb114 is safe, well-tolerated, and easy to administer, according to findings from an early-stage clinical trial published in The Lancet. Eighteen healthy adults...

Alachua, Florida biologics contract development and manufacturing organization (CDMO), Ology Bioservices, Inc., announced this week that it was awarded an Other Transaction Agreement (OTA) to support the...